S'abonner

High Incidence of Autonomic Dysfunction and Postural Orthostatic Tachycardia Syndrome in Patients with Long COVID: Implications for Management and Health Care Planning - 28/07/23

Doi : 10.1016/j.amjmed.2023.06.010 
Marie-Claire Seeley, MNurs a, b, Celine Gallagher, PhD a, b, Eric Ong, BMedSci a, c, Amy Langdon, BHealthSci a, c, Jonathan Chieng, BHealthMedSci a, Danielle Bailey, BHealthMedSci a, Amanda Page, PhD d, Han S. Lim, MBBS, PhD e, Dennis H. Lau, MBBS, PhD a, b,
a Australian Dysautonomia and Arrhythmia Research Collaborative, Faculty of Health and Medical Sciences, The University of Adelaide, South Australia, Australia 
b South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia 
c College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia 
d Faculty of Health and Medical Sciences, University of Adelaide, South Australia, Australia 
e Austin and Northern Health, The University of Melbourne, Victoria, Australia 

Requests for reprints should be addressed to Dennis H. Lau, MBBS, PhD, Department of Cardiology, Royal Adelaide Hospital, 1 Port Road, Adelaide, SA 5000, AUSTRALIA.Department of CardiologyRoyal Adelaide Hospital1 Port RoadAdelaideSA5000AUSTRALIA

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Sous presse. Épreuves corrigées par l'auteur. Disponible en ligne depuis le Friday 28 July 2023

Abstract

Background

Autonomic dysfunction, including postural orthostatic tachycardia syndrome (POTS), has been reported in individuals with post-acute sequelae of COVID-19 (PASC). However, the degree of dysautonomia in PASC has not been compared to those with POTS and healthy controls.

Methods

All participants were prospectively enrolled between August 5, 2021 and October 31, 2022. Autonomic testing included beat-to-beat hemodynamic monitoring to assess respiratory sinus arrhythmia, Valsalva ratio, and orthostatic changes during a 10-minute active standing test, as well as sudomotor assessment. The Composite Autonomic Symptom Score (COMPASS-31) was used to assess symptoms and the EuroQuol 5-Dimension survey (EQ-5D-5L) was used to assess health-related quality of life (HrQoL) measures.

Results

A total of 99 participants (n = 33 PASC, n = 33 POTS, and n = 33 healthy controls; median age 32 years, 85.9% females) were included. Compared with healthy controls, the PASC and POTS cohorts demonstrated significantly reduced respiratory sinus arrhythmia (P < .001), greater heart rate increase during 10-minute active standing test (P < .001), greater burden of autonomic dysfunction evidenced by higher COMPASS-31 scores across all subdomains (all P < .001), and poor HrQoL across all EQ-5D-5L domains (all P < .001), lower median EuroQol-visual analogue scale (P < .001), and lower utility scores (P < .001). The majority (79%) of those with PASC met the internationally established criteria for POTS.

Conclusion

The prevalence of autonomic symptomology for POTS was high in those with PASC, leading to poor HrQoL and high health disutility. Autonomic testing should be routinely undertaken in those with PASC to aid diagnosis and direct appropriate management to improve health outcomes.

Le texte complet de cet article est disponible en PDF.

Graphical Abstract




 : 

High incidence of autonomic dysfunction with high symtom burden and significant impairment in health-related quality of life in those with PASC


High incidence of autonomic dysfunction with high symtom burden and significant impairment in health-related quality of life in those with PASCImage, graphical abstract

Le texte complet de cet article est disponible en PDF.

Keywords : Autonomic function, Dysautonomia, Long COVID, Orthostatic intolerance, Post-acute sequelae of COVID-19, Postural orthostatic tachycardia syndrome


Plan


 Funding: This work was supported by a research grant from Standing up to POTS (North Hampton, Ohio, USA) and an equipment grant from The Australian POTS Foundation (Adelaide, SA, Australia).
 Conflicts of Interest: M-CS is supported by an Australian Government Research scholarship; DHL reports that the University of Adelaide has received on his behalf lecture and/or consulting fees from Abbott Medical, Biotronik, Medtronic, and MicroPort CRM. All other authors have no conflicts of interest to declare.
 Authorship: All authors contributed significantly to this work and had access to the data, with role in writing the manuscript.
 Trial registration: ANZCTR 12621000476831


© 2023  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.